Sleep Duration and Disruption and Prostate Cancer Risk: a 23-Year Prospective Study

Overview

Journal Cancer Epidemiol Biomarkers Prev

Specialties Biochemistry
Oncology
Public Health

Date 2015 Dec 18

PMID 26677208

Citations 29

Authors

Sarah C Markt

Erin E Flynn-Evans

Unnur A Valdimarsdottir

Lara G Sigurdardottir

Rulla M Tamimi

Julie L Batista

Sebastien Haneuse

Steven W Lockley

Meir Stampfer

Kathryn M Wilson

Charles A Czeisler

Jennifer R Rider

Lorelei A Mucci

Affiliations

Soon will be listed here.

Abstract

Background: Sleep deficiency is a major public health problem. There are limited human data on whether sleep duration or disruption are risk factors for prostate cancer.

Methods: We prospectively followed 32,141 men in the Health Professionals Follow-Up Study who reported their typical sleep duration in 1987, 2000, and 2008. We identified 4,261 incident prostate cancer cases, including 563 lethal cases through 2010. Sleep disruption was assessed in 2004 among 19,639 men, with 930 prostate cancer cases (50 lethal) identified from 2004 to 2010. Cox proportional hazards models were used to evaluate the association between sleep insufficiency and risk of overall and lethal prostate cancer.

Results: In 1987, 2% of men reported sleeping ≤5 hours per night. We found no association between habitual sleep duration or change in sleep duration with the risk of advanced or lethal prostate cancer. We also found no association between waking up during the night, difficulty falling asleep, or waking up too early, and risk of prostate cancer. In 2004, 6% of men reported never feeling rested when they woke up; these men had an increased risk of developing lethal prostate cancer compared with those who reported always feeling rested when they woke up (RR, 3.05; 95% CI, 1.15-8.10).

Conclusions: We found no consistent association between self-reported sleep duration or sleep disruption and any of our prostate cancer outcomes.

Impact: We did not find support for a consistent association between self-reported sleep and risk of advanced or lethal prostate cancer in this large cohort of men.

Citing Articles

Sleep and liver function biomarkers in relation to risk of incident liver cancer: a nationwide prospective cohort study.

Song J, Fan L, Shi D, Lai X, Wang H, Liu W BMC Med. 2024; 22(1):261.

PMID: 38915009 PMC: 11197319. DOI: 10.1186/s12916-024-03440-w.

A review for the impacts of circadian disturbance on urological cancers.

Li T, Jiang Y, Bai Y, Jiang K, Du G, Chen P Sleep Biol Rhythms. 2024; 22(2):163-180.

PMID: 38524168 PMC: 10959858. DOI: 10.1007/s41105-023-00500-1.

Sleep disorders and cancer incidence: examining duration and severity of diagnosis among veterans.

Burch J, Delage A, Zhang H, McLain A, Ray M, Miller A Front Oncol. 2024; 14:1336487.

PMID: 38469244 PMC: 10927008. DOI: 10.3389/fonc.2024.1336487.

Eyes Wide Open: Sleep as a Potential Contributor to Racial and Ethnic Disparities in Cancer.

Barber L, McCullough L, Johnson D Cancer Epidemiol Biomarkers Prev. 2024; 33(4):471-479.

PMID: 38270540 PMC: 10990828. DOI: 10.1158/1055-9965.EPI-23-1117.

Poor sleep quality association with higher lung cancer risk: a nested case-control study.

Ruan G, Wei Y, Ge Y, Liu L, Zhou Z, Siddiqi S PeerJ. 2023; 11:e16540.

PMID: 38111660 PMC: 10726752. DOI: 10.7717/peerj.16540.

References

Parent M, El-Zein M, Rousseau M, Pintos J, Siemiatycki J . Night work and the risk of cancer among men. Am J Epidemiol. 2012; 176(9):751-9. DOI: 10.1093/aje/kws318. View

Wilson K, Giovannucci E, Mucci L . Lifestyle and dietary factors in the prevention of lethal prostate cancer. Asian J Androl. 2012; 14(3):365-74. PMC: 3720164. DOI: 10.1038/aja.2011.142. View

von Ruesten A, Weikert C, Fietze I, Boeing H . Association of sleep duration with chronic diseases in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. PLoS One. 2012; 7(1):e30972. PMC: 3266295. DOI: 10.1371/journal.pone.0030972. View

West K, Jablonski M, Warfield B, Cecil K, James M, Ayers M . Blue light from light-emitting diodes elicits a dose-dependent suppression of melatonin in humans. J Appl Physiol (1985). 2010; 110(3):619-26. DOI: 10.1152/japplphysiol.01413.2009. View

Gooley J, Chamberlain K, Smith K, Khalsa S, Rajaratnam S, Van Reen E . Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans. J Clin Endocrinol Metab. 2011; 96(3):E463-72. PMC: 3047226. DOI: 10.1210/jc.2010-2098. View

Kakizaki M, Inoue K, Kuriyama S, Sone T, Matsuda-Ohmori K, Nakaya N . Sleep duration and the risk of prostate cancer: the Ohsaki Cohort Study. Br J Cancer. 2008; 99(1):176-8. PMC: 2453016. DOI: 10.1038/sj.bjc.6604425. View

. Perceived insufficient rest or sleep--four states, 2006. MMWR Morb Mortal Wkly Rep. 2008; 57(8):200-3. View

Gangwisch J, Heymsfield S, Boden-Albala B, Buijs R, Kreier F, Pickering T . Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep. 2008; 30(12):1667-73. PMC: 2276127. DOI: 10.1093/sleep/30.12.1667. View

Giovannucci E, Liu Y, Platz E, Stampfer M, Willett W . Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer. 2007; 121(7):1571-8. PMC: 2430098. DOI: 10.1002/ijc.22788. View

10.

Buja A, Lange J, Perissinotto E, Rausa G, Grigoletto F, Canova C . Cancer incidence among male military and civil pilots and flight attendants: an analysis on published data. Toxicol Ind Health. 2006; 21(10):273-82. DOI: 10.1191/0748233705th238oa. View

11.

Taheri S, Lin L, Austin D, Young T, Mignot E . Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med. 2004; 1(3):e62. PMC: 535701. DOI: 10.1371/journal.pmed.0010062. View

12.

Lockley S, Skene D, Arendt J . Comparison between subjective and actigraphic measurement of sleep and sleep rhythms. J Sleep Res. 1999; 8(3):175-83. DOI: 10.1046/j.1365-2869.1999.00155.x. View

13.

Brzezinski A . Melatonin in humans. N Engl J Med. 1997; 336(3):186-95. DOI: 10.1056/NEJM199701163360306. View

14.

Alvarez G, Ayas N . The impact of daily sleep duration on health: a review of the literature. Prog Cardiovasc Nurs. 2004; 19(2):56-9. DOI: 10.1111/j.0889-7204.2004.02422.x. View

15.

Buxton O, Marcelli E . Short and long sleep are positively associated with obesity, diabetes, hypertension, and cardiovascular disease among adults in the United States. Soc Sci Med. 2010; 71(5):1027-36. DOI: 10.1016/j.socscimed.2010.05.041. View

16.

Grandner M, Hale L, Moore M, Patel N . Mortality associated with short sleep duration: The evidence, the possible mechanisms, and the future. Sleep Med Rev. 2009; 14(3):191-203. PMC: 2856739. DOI: 10.1016/j.smrv.2009.07.006. View

17.

Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Bouvard V . Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 2009; 8(12):1065-6. DOI: 10.1016/S1470-2045(07)70373-X. View

18.

Lauderdale D, Knutson K, Yan L, Liu K, Rathouz P . Self-reported and measured sleep duration: how similar are they?. Epidemiology. 2008; 19(6):838-45. PMC: 2785092. DOI: 10.1097/EDE.0b013e318187a7b0. View

19.

Sigurdardottir L, Markt S, Rider J, Haneuse S, Fall K, Schernhammer E . Urinary melatonin levels, sleep disruption, and risk of prostate cancer in elderly men. Eur Urol. 2014; 67(2):191-4. PMC: 4318783. DOI: 10.1016/j.eururo.2014.07.008. View

20.

Wu A, Wang R, Koh W, Stanczyk F, Lee H, Yu M . Sleep duration, melatonin and breast cancer among Chinese women in Singapore. Carcinogenesis. 2008; 29(6):1244-8. PMC: 2574570. DOI: 10.1093/carcin/bgn100. View